Overview

Detailed Summary

Camlin Fine Sciences Limited is an India‑headquartered specialty chemicals manufacturer producing antioxidants, aroma ingredients (vanillin/ethyl vanillin), value‑added blends, and performance chemicals with global manufacturing and application laboratories, serving food, feed, nutraceutical, fragrance and industrial end markets across 80+ countries.
Q3 FY26 consolidated revenue was Rs. 4,572 million (up ~6% YoY) while adjusted EBITDA contracted to Rs. 307 million (6.7% margin) and PAT turned negative due to exceptional items, FX adjustments and higher operating costs; management highlighted tariff dynamics, inventory phasing and acquisition costs as primary drivers of near‑term margin pressure.
Vanillin is a major strategic lever: Camlin Fine Sciences delayed some sales to capture tariff benefits, expects improved realizations following US tariff reductions, and targets 4,000 tonnes of Vanillin in FY27 — a potential material revenue and margin driver if channel stocks and tariffs evolve favorably.
The company is actively reshaping its footprint — acquiring Vinpai to enter natural functional ingredients and scaling Vitafor in animal nutrition while pursuing liquidation of loss‑making European and Chinese subsidiaries to stop cash burn, representing simultaneous portfolio expansion and pruning.
Near‑term operational risks include a fire at a Brazil plant (insurer survey ongoing, book loss ~Rs. 32.7 crore reported), tariff sensitivity in Vanillin realizations, and structural pricing pressure in straights; management expects these to be transitory but they materially affect quarterly performance.

Sector: Chemicals & Petrochemicals
Industry: Specialty Chemicals
Market Cap: 1,992 Cr
Volatility: High Risk
P/E Ratio: -51.8
Industry P/E: 42.1
PEG Ratio: —
P/B Ratio: 2.0
52W High: 334.70
52W Low: 96.30

Sales CAGR

1Y: 14.62%
3Y: 8.95%
5Y: 8.86%
10Y: 8.58%

Profit CAGR

1Y: -50.76%
3Y: —
5Y: —
10Y: —

ROE

TTM: 2.35%
3Y: -7.03%
5Y: -1.69%
10Y: -0.73%

ROCE

TTM: 8.04%
3Y: 6.80%
5Y: 8.88%
10Y: 9.36%

Technicals

‌

Forecasts

Unlock more with professional

Analyst Target, Price, EPS and Revenue Projections
Get In-depth insights on EPS and Revenue forecasts

Peers

Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals

Symbol	Watchlist	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
BEPL		88.80	2,557 Cr	13.14	2.46	3.89	16.05	21.91	14.35
DDEVPLSTIK		236.35	2,466 Cr	12.29	2.69	0.73	21.57	30.30	16.21
SHK		120.00	2,063 Cr	9.77	1.55	0.67	7.50	7.42	6.05
CAMLINFINE		103.00	1,992 Cr	-51.84	2.01	0.00	2.35	8.04	-3.07
TITANBIO		504.00	1,941 Cr	15.31	11.67	0.09	13.86	16.04	12.18
YASHO		1439.00	1,833 Cr	94.92	4.29	0.03	2.97	7.66	1.60
VIDHIING		316.00	1,585 Cr	33.23	5.12	1.10	15.48	19.14	11.52
Median: 7 Co.	—	236.35	1,992 Cr	13.14	2.69	0.67	13.86	16.04	11.52

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

Total Figures

QoQ Changes

Total Figures

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Sales	406	386	402	396	423	433	437	424	460	457
Expenses	381	363	415	378	380	385	378	405	426	435
Operating Profit	25	23	-13	18	43	49	59	19	33	22
OPM %	6.19	6.05	-3.30	4.58	10.22	11.26	13.58	4.49	7.27	4.82
Other Income	1.76	1.66	-44	1.87	-138	-0.51	5.79	9.45	4.23	-15
Interest	20	14	16	23	26	34	16	16	19	18
Depreciation	19	21	20	20	21	14	18	17	19	17
Profit Before Tax	-12	-9.73	-94	-23	-142	-0.33	31	-4.26	-0.09	-28
Tax %	-72.29	-46.76	12.53	-47.57	18.41	-2,163.64	25.90	0.23	-6,566.67	-0.18
Net Profit	-21	-14	-82	-35	-116	-7.47	23	-4.25	-6.00	-28
EPS in Rs	-1.01	-0.61	-3.99	-1.75	-5.17	-0.21	1.13	-0.51	-0.74	-1.87

Consolidated Profit Loss (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	547	723	892	1,049	1,187	1,412	1,682	1,613	1,667	1,717
Expenses	506	708	824	918	1,005	1,259	1,476	1,539	1,458	1,547
Operating Profit	41	15	69	131	182	153	205	74	208	170
OPM %	7.52	2.04	7.70	12.46	15.33	10.82	12.21	4.58	12.49	9.93
Other Income	15	12	14	3.43	4.98	33	-3.88	-34	5.08	-124
Interest	27	28	37	43	38	36	59	60	100	92
Depreciation	22	27	29	33	44	56	63	79	64	70
Profit Before Tax	-6.02	-31	17	58	105	94	80	-99	49	-116
Tax %	26.22	21.98	81.99	48.75	37.81	35.76	50.47	-5.67	0.13	9.56
Net Profit	-4.44	-24	3.01	30	65	60	40	-105	49	-105
EPS in Rs	-0.54	-2.10	0.03	1.57	2.54	2.93	2.69	-4.80	-6.00	-1.99
Dividend Payout %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	9.67	10	12	12	12	13	16	16	17	19
Reserves	167	202	359	359	391	631	732	804	848	883
Borrowings	167	321	357	438	503	502	646	801	683	681
Other Liabilities	139	139	288	278	328	336	406	440	404	441
Total Liabilities	483	673	1,016	1,087	1,234	1,482	1,800	2,060	1,952	2,024
Fixed Assets	140	199	276	270	304	581	601	858	816	702
CWIP	25	7.62	14	59	179	24	215	43	46	9.73
Investments	1.09	21	117	13	9.43	9.43	7.23	7.96	7.88	63
Other Assets	316	445	609	745	742	867	977	1,152	1,082	1,249
Total Assets	483	673	1,016	1,087	1,234	1,482	1,800	2,060	1,952	2,024

Consolidated Cash Flows (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	72	-8.69	-15	-9.00	86	117	145	51	139	27
Cash from Investing Activity	-66	-70	-149	-1.94	-90	-133	-249	-125	-66	-75
Cash from Financing Activity	-6.87	91	182	26	3.25	39	136	60	-86	72
Net Cash Flow	-0.97	13	18	15	-0.85	23	32	-14	-13	24

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Jan 2025	Mar 2025	Jun 2025	Sep 2025	Nov 2025	Dec 2025	Mar 2026
Promoters	48.03%	48.03%	48.02%	48.02%	48.02%	49.10%	49.10%	49.10%	49.08%	48.03%	49.08%	48.03%
FIIs	0.99%	1.69%	1.01%	0.81%	0.76%	0.82%	1.47%	2.88%	2.12%	2.15%	2.12%	0.94%
DIIs	3.75%	4.54%	4.89%	4.24%	3.39%	4.09%	3.83%	4.14%	5.48%	7.78%	5.48%	7.70%
Public	47.22%	45.74%	46.08%	46.93%	47.83%	45.99%	45.61%	43.87%	43.33%	42.05%	43.33%	43.32%
Total Shareholders	62,098	58,165	62,687	67,750	61,893	60,554	58,111	59,538	57,661	52,845	57,661	52,232

Market Transactions

Unlock more with professional

Real-time bulk & block deal transactions
Export transaction data for analysis

Projection

Unlock more with professional

Analyst Target, Price, EPS and Revenue Projections
Get In-depth insights on EPS and Revenue forecasts

Documents

Presentations

Concalls

Reports

Presentations

Investor Presentation

Q3 FY26

Investor Presentation

Q2 FY26

Investor Presentation

Q1 FY26

Available on Pro Plan